Drug Shortage Report for SUPREFACT

Last updated on 2020-02-19 History
Report ID 104798
Drug Identification Number 02225166
Brand name SUPREFACT
Common or Proper name Suprefact
Company Name CHEPLAPHARM ARZNEIMITTEL GMBH
Market Status MARKETED
Active Ingredient(s) BUSERELIN
Strength(s) 1MG
Dosage form(s) SOLUTION
Route of administration SUBCUTANEOUS
Packaging size 2
ATC code L02AE
ATC description HORMONES AND RELATED AGENTS
Reason for shortage Other (Please describe in comments)
Anticipated start date 2020-01-29
Actual start date
Estimated end date 2020-02-14
Actual end date 2020-02-18
Shortage status Resolved
Updated date 2020-02-19
Company comments Delay in production - The availability date represents estimated availability at the main Sanofi warehouse. Availability dates at a customer’s usual distributor warehouse may vary. Pharmacies are invited to communicate with their preferred distributor to obtain the product availability date. Patients should validate the availability of the product with their respective pharmacy.
Health Canada comments
Tier 3 Status No
Contact Address ZIEGELHOF 24
GREIFSWALD, MECKLENBURG - WEST POMERANIA
GERMANY 17489
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v5 2020-02-19 English Compare
v4 2020-02-18 French Compare
v3 2020-02-18 English Compare
v2 2020-01-30 French Compare
v1 2020-01-30 English Compare

Showing 1 to 5 of 5